2011
DOI: 10.1016/j.eururo.2011.07.051
|View full text |Cite
|
Sign up to set email alerts
|

Antegrade Perfusion With Bacillus Calmette-Guérin in Patients With Non–Muscle-Invasive Urothelial Carcinoma of the Upper Urinary Tract: Who May Benefit?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
71
0
2

Year Published

2013
2013
2019
2019

Publication Types

Select...
4
3
2

Relationship

0
9

Authors

Journals

citations
Cited by 117 publications
(74 citation statements)
references
References 17 publications
1
71
0
2
Order By: Relevance
“…Researchers have therefore extended this experience over to UTUC patients, using antegrade instillation of either agent into the upper urinary tract by percutaneous nephrostomy [61], or retrograde instillation through a ureteric stent or with the help of vesicoureteral reflux created by a double-pigtail catheter [62]. This may be useful particularly in those not eligible for surgery, with favorable medium term results similar to those observed in the bladder cancer experience [61]. Studies have also found that BCG therapy may prevent patients from requiring dialysis and provide cure for those with carcinoma in situ of the upper urinary tract [63].…”
Section: Intraluminal Therapymentioning
confidence: 99%
“…Researchers have therefore extended this experience over to UTUC patients, using antegrade instillation of either agent into the upper urinary tract by percutaneous nephrostomy [61], or retrograde instillation through a ureteric stent or with the help of vesicoureteral reflux created by a double-pigtail catheter [62]. This may be useful particularly in those not eligible for surgery, with favorable medium term results similar to those observed in the bladder cancer experience [61]. Studies have also found that BCG therapy may prevent patients from requiring dialysis and provide cure for those with carcinoma in situ of the upper urinary tract [63].…”
Section: Intraluminal Therapymentioning
confidence: 99%
“…1 Drawing on the bladder cancer literature, topical chemotherapy has been administered after endoscopic treatment of upper tract urothelial carcinoma (UUC). [2][3][4][5][6][7] Dwell time of topical chemotherapy in the upper tract, however, is poor, and recurrence rates remain high, ranging from 29% to 54%.…”
Section: Introductionmentioning
confidence: 99%
“…Previously, several adjuvant topical agents, including Bacillus Calmette-Guérin (BCG), mitomycin C, epirubicin and thiotepa, have been used for UTUC perfusion treatment (4,8). Benefits of the antegrade perfusion with BCG in patients with UTUC following ablation of early stage tumors has also been demonstrated (8).…”
mentioning
confidence: 99%
“…Benefits of the antegrade perfusion with BCG in patients with UTUC following ablation of early stage tumors has also been demonstrated (8). Nonetheless, certain controversy remains regarding the safety and efficacy of retrograde instillations, which may cause pyelovenous influx and ureteric obstruction during perfusion (4).…”
mentioning
confidence: 99%